Asthma drugs for

It is important to include all age ranges that are of clinical importance. Development of an anti-asthma drug, for example, should include a programme of evaluation in children as well as adults because they will form a significant portion of the database and risk-benefit considerations will be different. Development of an anti-arthritis compound, on the other hand, will be undertaken predominantly in older patients and particularly detailed information on efficacy and safety in the elderly will be required. 

Leath TM, Singla M, Peters SP (2005) Novel and emerging therapies for asthma. Drug Discov Today 10 1647-1655... 

In the USA, LTRAs have largely replaced theophylline as the incremental drug for the treatment of moderate and severe asthma, where LABA plus ICS alone do not provide adequate control. For patients with mild persistent asthma, LTRAs have been designated as a suitable substitute for low dose ICS by the National Asthma Education Panel Program (NAEPP) of the National Heart and Lung Institute (National Institutes of Health). However, inhaled ICS are more efficacious. 

One class of stimulants, the amphetamines, was synthesized originally as possible alternative drugs for the treatment of asthma and was a principal component of the original Benzedrine . Amphetamine-like stimulants are known and consumed especially for their activity-sustaining effects (i.e. increased alertness, strength, and endurance). Their wake-promoting properties... 

And finally, Structure 5.2 and Spectrum 5.8 show a classic example of a 1,2,4 tri-substituted benzene ring, (a well known anti-asthma drug, salbutamol). Obviously, the scope for variation in these systems is vast ... 

Asthma is the most serious of the atopic diseases and has become epidemic, affecting more than 155 million individuals in the developed world. It is the most common chronic childhood disease in developed nations [1], and carries a very substantial direct and indirect economic cost worldwide [2]. A number of pharmacological treatments have been developed for asthma. These treatments have a modest efficacy overall, due in part to widely variable individual responses to asthma drugs. Because of such variability, it is clear that some of the substantial resources expended on asthma medication, estimated to exceed U.S. 3 billion per annum in the U.S. alone [3], would be better spent targeting those patients who... 

Dosages of Drugs for Acute Severe Exacerbations of Asthma in the Emergency Department or Hospital... 

Figure 13.4 presents the mass spectrum and distribution of the molecular ion of salbutamol (mass 240 u), the asthma drug, which is commercially produced as a coating on micron-sized sugar beads. For analysis a Bi3++ cluster gun was used. Before measurements the sample was sprayed onto a silicon substrate in order to disperse the beads [7],... 

L-699,392, Merck s drug for the treatment of chronic asthma, is an example of asymmetric amplification on an industrial scale (see Figure 13.19). The ketone reduction can be carried out stoichiometrically with a borane-(-)-a-pinene reagent. The terpene natural products are often mixtures of isomers and enantiomers. A reagent prepared from 98% optically pure (-)-a-pinene gives a product e.e. of 97%, but a reagent prepared from less expensive 70% optically pure (-)-a-pinene yields a product e.e. of 95%, which can be pushed to >99.5% by using an excess [30]. 

---